Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin

Life Sciences

Volumn 61, Issue 4, 1997, Pages 437-443

  Mahle, Christina ^a   Dasgupta, Amitava ^a,b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

Author keywords

Antioxidant capacity; Lipid hydroperoxide; Phenytoin

Indexed keywords

10N METHYLCARBAMYL 3,7 DIMETHYLAMINO 10H PHENOTHIAZINE; 2,2' AMINO BIS(3 ETHYLBENZTHIAZOLE SULPHONATE); CHOLESTEROL; CHROMOGENIC SUBSTRATE; FREE RADICAL; HYDROGEN PEROXIDE; LIPID HYDROPEROXIDE; METHYLENE BLUE; METMYOGLOBIN; MYOGLOBIN; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; PROTEIN; THIAZOLE DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CONTROLLED STUDY; EPILEPSY; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; SERUM;

ANTIOXIDANTS; CHOLESTEROL; EPILEPSY; FREE RADICALS; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; OXIDATION-REDUCTION; PHENYTOIN; TRIGLYCERIDES;

MURINAE;

EID: 0030794291     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00401-3     Document Type: Article

References (26)

1. J.L. MARX, Science 235 529-531 (1987).
2. R.F. DEL MASETRO, Acta Physiol Scand (Suppl) 492 153-168 (1980).
3. A. LEDWOZYW, J. MICHALAK, A. STEPIEN and A. KADZIOLKA, Clin Chem Acta 155 275-284
4. P.A. SOUTHERN and G. POWIS, Mayo Clin Proc 63 381-389 (1988).
5. D. STEINBERG, S. PARTHASARATHY, T.E. CAREW, J.C. KHOO, and J.L. WITZTUM, N Eng J Med 320 915-924 (1989).
6. D.W. MOREL, P.E. DICORLETO, and M. CHISOLM, Arteriosclerosis 4 357-364 (1984).
7. D. STEINBERG, Circulation 84 1420-1425 (1991).
8. J. LUNG, S.P. HALLORAN, A.C. WHITE, and T. DORMANDY, J Rheumatol 8 233-245 (1981).
9. M.I.S. HUNTER, B.C. NLEMADIM, and D.L.W. DAVIDSON, Neurochem Res 10 1645-1652 (1985).
10. I. NISHIGAKI, M. HAGIHARA, H. TSEUNEKAWA, M. MASEKI, and K. YAGI, Biochem Med 25 373-378 (1981).
11. K. YAGI, Lipid peroxidation in biology and medicine (ed K. YOGI), Academic Press, New York, 223-243 (1982).
12. J. KEDZIORA, G. BARTOSZ, J. GROMADZINSKIA, M. SKLODOWSKA, W. WESOWICZ, and J. SCIANOWSKI, Clin Chem acta 15 191-194 (1986).
13. J.A. KNIGHT, A.K. CHEUNG, R.K. PIPPER, and K. SERVILLA, Ann Clin Lab sci 19 238-241 (1989).
14. J.A. KNIGHT, R.K. PIPER, S.E. SMITH, and H.H. CROCKETT, Ann Clin Lab Sci 18 374-377 (1988).
15. J.A. KNIGHT, Ann Clin Lab Sci 25 111-121 (1995).
16. R. HOLCOMB, R. LYNN, B. HARVEY, B.J. SWEETMAN, and N. GERBER, J Pediatr 80 627-632 (1972).
17. R.M. MCCLAIN, and C. LANGHOFF, Teratology 21 371-379 (1980).
18. L. LIU, and P.G. WELLS, Toxicol Appl Pharmacol 134 71-80 (1995).
19. S. KUBOW, and P.G. WELLS, Mol Pharmacol 35 504-511 (1989).
20. D.C. MAYS, L.J. PAWLUK, G. APSELOFF, W. B. DAVIS, Z.W. SHE, A.R. SAGONE, and N. GERBER, Biochem Pharmacol 50 367-380 (1995).
21. S. PERVAIZ, A. HARRIMAN, and KS GULLIYA, Free Radical Biol Med 12 389-396 (1992).
22. P.C. SHARPE, L.T. MCGRATH, E. MCCLEAN, I.S. YOUNG, and G.P.R. ARCHBOLD, Q J Med 88 101-108 (1995).
23. J.I. TENG, and L.L. SMITH, Bioorganic Chem 5 99-119 (1976).
24. A. SEVANIAN, and L.L. MCLEOD, Lipids 22 627-636 (1987).
25. W.K. YU, and P.G. WELLS, Toxicol Appl Pharmacol 131 1-12 (1995).
26. P.G. WELLS, M.K. NAGAI, and G. SPANO GRECO Toxicol Appl Pharmacol 97 406-414 (1989).